Results 21 to 30 of about 18,058,309 (312)

Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine

open access: yesNature Communications, 2022
In this phase 2 clinical trial, the authors assess protective efficacy of a Plasmodium vivax circumsporozoite vaccine in naïve and semi-immune individuals from controlled human malaria infection as well as antibody and IFN-γ response to vaccination.
Myriam Arévalo-Herrera   +11 more
doaj   +1 more source

An innovative method for accelerating vaccine formulation development and manufacturing process: Using prefabricated vaccine base (standardized mixtures of vaccine excipients)

open access: yes, 2021
Vaccine base can be defined as a standardized mixtures of vaccine excipients such as adjuvants emulsifier, preservatives, stabilizer, surfactant, buffers and etc.
Berhanu, Mulugeta, Mulugeta Berhanu
core   +1 more source

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2

open access: yesVaccines, 2023
(1) Background: We previously reported the development of a recombinant protein SARS-CoV-2 vaccine, consisting of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, adjuvanted with aluminum hydroxide (alum) and CpG oligonucleotides.
Syamala Rani Thimmiraju   +22 more
doaj   +1 more source

Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease

open access: yesHuman Vaccines & Immunotherapeutics, 2017
A therapeutic vaccine for human Chagas disease is under development by the Sabin Vaccine Institute Product Development Partnership. The aim of the vaccine is to significantly reduce the parasite burden of Trypanosoma cruzi in humans, either as a ...
Christopher A. Seid   +15 more
doaj   +1 more source

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

open access: yes, 2012
[[abstract]]Enterovirus 71 (EV71) has recently emerged as an important neurotropic virus in Asia because effective medications and prophylactic vaccine against EV71 infection are not available.
Chang, JY;Chang, CP;Tsai, HH;Lee, CD;Lian, WC;Ih Jen, S;Sai, IH;Liu, CC;Chou, AH;Lu, YJ;Chen, CY;Lee, PH;Chiang, JR;Chong, PC
core   +1 more source

Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Rotavirus is one of the main pathogens causing severe diarrhea in infants and young children < 5 years of age. The development of the next-generation rotavirus vaccine is of great significance for preventing rotavirus infection and reducing severe ...
Yan Zhou   +16 more
doaj   +1 more source

Malaria vaccine developments

open access: yesThe Lancet, 2004
Large gains in the reduction of malaria mortality in the early 20th century were lost in subsequent decades. Malaria now kills 2-3 million people yearly. Implementation of malaria control technologies such as insecticide-treated bednets and chemotherapy could reduce mortality substantially, but an effective malaria vaccine is also needed.
Moorthy, V, Good, M, Hill, A
openaire   +3 more sources

Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development

open access: yes, 2004
[[abstract]]Enterovirus 71 (EV71) is an enterovirus that could lead to severe neurological disorders and fatalities. The inactivated vaccine is an appropriate EV71 vaccine format for meeting current needs.
Wu, SC; Liu, CC; Lian, WC   +3 more
core   +1 more source

Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Immune responses to 13-valent pneumococcal conjugate vaccine (PCV13) and quadrivalent inactivated influenza vaccine (QIV) in older adults may vary with coadministration and previous pneumococcal polysaccharide vaccination.
Allison R. Thompson   +11 more
doaj   +1 more source

Development of antistaphylococcal vaccines [PDF]

open access: yesCurrent Infectious Disease Reports, 2001
Staphylococcus aureus is frequently isolated from both hospital-acquired and community-acquired infections, and the emergence of antibiotic resistance among clinical isolates has made treatment of staphylococcal infections difficult. This scenario has sparked renewed interest in the development of a vaccine for individuals at high risk for ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy